Frequency of anemia and its association with outcome (sustained virological response) in patients of chronic hepatitis C Geno 3, treated with standard interferon alpha 2a and ribavirin

Journal Title: Pakistan Journal of Pharmacology - Year 2012, Vol 29, Issue 2

Abstract

Chronic Hepatitis C is one of the leading cause of chronic liver disease globally. The past two decades have seen many advances in Hepatitis C treatment. Despite these advances side effects of treatment are common. Hematological complications of treatments can result in treatment cessation and suboptimal results We observed the development of haematological side effects chiefly anaemia and its effect on SVR in a cohort of 240 patients. The mean Haemoglobin at baseline was 13.2 gm, range 10.9-16, SD=0.8. At 6 months the mean Haemoglobin was 10.6 gm (7-11gm) SD=0.7. Clinically significant anaemia defined as haemoglobin of less than 10 gm/dl occurred in 56 % (n=134) of patients. Out of these 36% (n=48) were males and 64% (n=86) were females. More than 69 % of the total cohort (n=165 pts) experienced a drop of Hb of ≥ 3 gm/dl. Hemoglobin decreased by 2.8 gm at week 4 in 44% of patients and by 3.5 gm in 25% of patients at 3 months. A decrement in Hb of upto 2.9% was seen at the end of 6 months of treatment.The P value is < 0.05, this difference is considered to be statistically significant. Overall SVR was 71%. SVR rates in those who developed anaemia was 76% and in those who did not develop anaemia was 68%. The P value equals 0.5, this difference is considered to be not statistically significant. Anaemia is a frequent complication of interferon and ribavirin treatment for chronic hepatitis C and needs management with dose reduction and erythropoietin to optimize SVR. Erythropoietic agents are effective in treating anemia, preventing ribavirin dose reduction and improving patient’s quality of life.

Authors and Affiliations

Musarrat Iqbal, Akbar Waheed, Saleem Qureshi

Keywords

Related Articles

Comparison of body weight, absolute and relative weight of pituitary gland in carbimazole and carbimazole plus thyroxin treated male albino rats

Overt hypothyroidism and hyperthyroidism may be associated with weight gain and loss. The present study was designed to determine the effects of Carbimazole, an antithyroid drug (ATD) used in the treatment of hyperthyroi...

Epidemiology and symptomatology of exudative and transudative type of ascites in hospitalized patients

Ascites is the pathological accumulation of fluid in the peritoneal cavity, associated with many clinical symptoms and had various causes. The descriptive observational study was carried out in admitted patients of Civil...

Moxifloxacin in the treatment of uncomplicated enteric fever

Many drugs have been used for the treatment of enteric fever. Moxifloxacin is a newer fluoroquinolone antibiotic also said to be effective against Salmonella typhi. In order to evaluate its effectiveness in our populati...

Incretin mimetics: new age drugs for type 2 diabetes mellitus

Type 2 diabetes mellitus is a fast growing global epidemic and its prevalence has increased in the 21st century. The rise in blood glucose levels is associated with complex pathogenesis which includes a significant reduc...

Lead induced effects on renal alkaline phosphatase with role of zinc in albino rats

Kidneys are adversely affected by a wide variety of therapeutic agents and chemicals including the environmental pollutants such as Lead. The nephrotoxic effects of lead have been widely studied. The proximal tubular cel...

Download PDF file
  • EP ID EP98464
  • DOI -
  • Views 139
  • Downloads 0

How To Cite

Musarrat Iqbal, Akbar Waheed, Saleem Qureshi (2012). Frequency of anemia and its association with outcome (sustained virological response) in patients of chronic hepatitis C Geno 3, treated with standard interferon alpha 2a and ribavirin. Pakistan Journal of Pharmacology, 29(2), 23-28. https://europub.co.uk./articles/-A-98464